Back to home » Treatment News
 November 29, 2007
|
Treating Anal Lesions Nonsurgically
Nonsurgical treatment of precancerous anal lesions using an infrared coagulator (IRC) has been found safe and effective in a small study, according to an article in the Journal of Immune Deficiency Syndromes.
|
|
|
November 28, 2007
|
Sculptra Modestly Improves Facial Wasting
Treatment with Sculptra (poly-L-lactic acid), one of two FDA-approved treatments for facial fat loss, results in only modest increases in tissue thickness but high patient satisfaction, according to a study published in the December 15 issue of the Journal of Acquired Immune Deficiency Syndromes.
|
|
|
November 27, 2007
|
Fosamax Safe and Effective for Bone Mineral Loss
Fosamax (alendronate sodium), added to calcium and vitamin D supplementation, is a safe and effective treatment option for HIV-positive people with bone mineral loss, according to final data from a clinical trial published in the November 30 issue of AIDS.
|
|
|
November 26, 2007
|
AIDS Activism Training in Atlanta, December 7 & 8
The AIDS Treatment Activists Coalition (ATAC), a national coalition of AIDS activists, will be conducting a training workshop on activism for HIV prevention, drug development and treatment access in Atlanta on December 7 and 8.
|
|
|
| November 20, 2007
|
| November 16, 2007
|
November 14, 2007
|
Suppressing HIV Doesn’t Stop Immune Activation
Signs of immune over-activation has been found in the spinal fluid of volunteers who have suppressed HIV to undetectable levels for four years, according to a newly published study in the Journal of Infectious Diseases.
|
|
|
November 13, 2007
|
FDA Approves Low-Dose Kaletra for Kids
The Food and Drug Administration has approved a new low-dose Kaletra (lopinavir/ritonavir) tablet, sold as Aluvia in many other parts of the world, for use in HIV-positive children, according to the drug’s maker, Abbott.
|
|
|
Herpes Drug Fights HIV Too
The anti-herpes drug Valtrex (valacyclovir) has been found to lower HIV viral load in the blood and genital secretions of men with underlying herpes simplex vius-2 (HSV-2) infection, according to a report on a study from AIDSmap.
|
|
|
November 12, 2007
|
People With Kidney Disease Undertreated for HIV
People with both HIV and kidney disease are not being treated appropriately for HIV, leading to greater death rates, say researchers of a new study published in Clinical Infectious Diseases.
|
|
|
| November 09, 2007
|
November 08, 2007
|
New Worries With AIDS Vaccine
Previous immunity to adenovirus 5 (Ad5), a common cold virus, may explain why volunteers receiving Merck’s preventive HIV vaccine may have been more likely to become infected with HIV than those receiving placebo injections, suggest researchers associated with the international STEP study.
|
|
|
November 07, 2007
|
Half of Patients Had AIDS at Time of HIV Diagnosis
A new study has found that half of people in the Veteran’s Administration (VA) medical system who tested HIV positive already had AIDS at the time of their diagnosis, according to an announcement by researchers at Yale and Yeshiva University.
|
|
|
November 06, 2007
|
Major Lab Company Licenses Tropism Test
Quest Diagnostics, the nation’s largest diagnostic testing company, has announced that it will begin offering an HIV tropism test, Pathway Diagnostics’ SensiTrop assay.
|
|
|
| November 05, 2007
|
| November 02, 2007
|
|
|
Have news about HIV? Send press releases, news tips and other announcements to news@poz.com. |
|
  November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
February 2006
|
